Item 7.01 Regulation FD Disclosure.

On January 14, 2021, Bicycle Therapeutics plc (the "Company") posted an updated corporate presentation on the Company's website. To access the presentation, investors should visit the "Investors & Media" section of the Company's website at investors.bicycletherapeutics.com.

The information furnished under this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or subject to the liabilities of that section. The information shall not be deemed incorporated by reference into any other filing with the Securities and Exchange Commission made by the Company, regardless of any general incorporation language in such filing.




Item 8.01 Other Events.

On January 14, 2021, the Company issued a press release announcing progress updates for its Bicycle Toxin Conjugates (BTCs) targeting oncological indications, as well as its Bicycle tumor-targeted immune cell agonists (TICAs™). A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.






(d)    Exhibits



Exhibit No. Description

99.1 Press release dated January 14, 2021.

© Edgar Online, source Glimpses